Summit-based pharmaceutical company Celgene Corp. is set to close on a $4.5 billion debt issue in a move tied in part to its $1 billion acquisition of Juno Therapeutics. The cash and stock acquisition of Juno was announced in June 2015 and …
To say 2017 was a tough year for Celgene Corporation (NASDAQ:CELG) and CELG stock would be a considerable understatement. Despite starting the year on the right foot and advancing 22% as of late September, bad R&D news …
Celgene turned in a brutal third-quarter earnings report, missing revenue forecasts and cutting its long-term profit outlook. Traders were woefully unhedged by several measures, leaving them vulnerable to feel the brunt of the stock's 20% drop. …
On Thursday before the open, Celgene Corporation (NASDAQ:CELG) reported its fourth-quarter earnings results. The company beat on earnings per share and revenue expectations. It also provided good, but not great guidance (more on …
A quick analysis of Celgene Corporation(NASDAQ: CELG) stock history reveals three distinct stages with four stock splits along the way. These stages led to the company becoming what the following chart shows it to be -- one of the …
Even some of the biggest and best have things go wrong every now and then. Celgene (NASDAQ: CELG) has been the best-performing biotech stock over the last five years among big biotechs with market caps over $50 billion. And now, …
Celgene (NASDAQ: CELG) stock has been in my investment portfolio since 2013. I enjoyed a couple of great years with the biotech stock performing really well. Over the past couple of years, however, Celgene hasn't generated high …
This article is the second in a two-part series on applying the principles of value investing. In part 1 found here my primary focus was on the benefits of investing in fundamentally strong dividend growth stocks when they are out of favor, and …
Celgene Corp. (NASDAQ: CELG) has decided to join the stock split game. Stock splits do not create any fundamental change on the surface, but the problem that Celgene has faced is that the run up in shares has lowered its average …